Media Contact:
Julie Cohen
Director of Marketing and Communications
Phone: 212.701.3614
Fax: 212.378.2410
jcohen@cahill.com

Firm News

Cahill Represents Financing Sources in Valeant and Biovail Merger

Date: 06/21/10

Cahill is representing the financing sources in connection with providing $2.8 billion of financing for the merger of specialty pharmaceuticals companies Valeant Pharmaceuticals International and Canada's Biovail Corp.

Attorney

Media Contact:
Julie Cohen
Director of Marketing and Communications
Phone: 212.701.3614
Fax: 212.378.2410
jcohen@cahill.com